These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. Mwatha JK; Kimani G; Kamau T; Mbugua GG; Ouma JH; Mumo J; Fulford AJ; Jones FM; Butterworth AE; Roberts MB; Dunne DW J Immunol; 1998 Feb; 160(4):1992-9. PubMed ID: 9469463 [TBL] [Abstract][Full Text] [Related]
4. Protein S and protein C anticoagulant activity in acute and chronic cardiac ischemic syndromes. Relationship to inflammation, complement activation and in vivo thrombin activity. D'Angelo A; Gerosa S; D'Angelo SV; Mailhac A; Colombo A; Agazzi A; Mazzola G; Chierchia S Thromb Res; 1994 Jul; 75(2):133-42. PubMed ID: 7974387 [TBL] [Abstract][Full Text] [Related]
5. T cell phenotype alterations in hepatosplenic schistosomiasis mansoni normalize after chemotherapy. Zwingenberger K; Harms G; Vergetti de Siqueira JG; Correia Dacal AR; Jansen-Rosseck R; Bienzle U; Feldmeier H Immunobiology; 1989 Oct; 179(4-5):342-52. PubMed ID: 2515152 [TBL] [Abstract][Full Text] [Related]
6. Plasma Endotoxin Levels Are Not Increased in Klemperer KM; Reust MJ; Lee MH; Corstjens PLAM; van Dam GJ; Mazigo HD; Dupnik KM; Downs JA Am J Trop Med Hyg; 2020 Jun; 102(6):1382-1385. PubMed ID: 32124718 [TBL] [Abstract][Full Text] [Related]
7. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease. Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668 [TBL] [Abstract][Full Text] [Related]
9. Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Abath FG; Morais CN; Montenegro CE; Wynn TA; Montenegro SM Trends Parasitol; 2006 Feb; 22(2):85-91. PubMed ID: 16380294 [TBL] [Abstract][Full Text] [Related]
10. Humoral immune responses in human hepatosplenic schistosomiasis mansoni. Goodgame RW; Colley DG; Draper CC; Lewis FA; McLaren ML; Pelley RP Am J Trop Med Hyg; 1978 Nov; 27(6):1174-80. PubMed ID: 727322 [TBL] [Abstract][Full Text] [Related]
11. The coagulation profile in hepatosplenic schistosomiasis. El-Bassiouni NE; El Bassiouny AE; Hussein NA; El-Sayed HH; Ibrahim IM; Lotfy MG; Omran SA Blood Coagul Fibrinolysis; 1998 Mar; 9(2):189-94. PubMed ID: 9622218 [TBL] [Abstract][Full Text] [Related]
12. Fibronectin, platelet factor 4 and beta-thromboglobulin in endemic hepatosplenic schistosomiasis: relation to acute hematemesis. el-Bassiouni NE; el Bassiouny AE; Akl MM; el-Khayat HR Haemostasis; 1997; 27(1):39-48. PubMed ID: 9097085 [TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis and the bleeding tendency in patients with hepatosplenic schistosomiasis. Omran SA; Hussein NA; Mohamed AA; el-Kaliouby AH; Hussein AT J Clin Pathol; 1990 Jun; 43(6):476-8. PubMed ID: 1696289 [TBL] [Abstract][Full Text] [Related]
14. Relationship between circulating antigen level and morbidity in Schistosoma mansoni-infected children evaluated by ultrasonography. Hassan MM; Hegab MH; Soliman SZ; Gaber OA; Shalaby MM; Kamel FM Am J Trop Med Hyg; 1999 Oct; 61(4):635-8. PubMed ID: 10548300 [TBL] [Abstract][Full Text] [Related]
15. Activation of the host response in human Plasmodium falciparum malaria: relation of parasitemia to tumor necrosis factor/cachectin, thrombin-antithrombin III, and protein C levels. Hemmer CJ; Kern P; Holst FG; Radtke KP; Egbring R; Bierhaus A; Nawroth PP; Dietrich M Am J Med; 1991 Jul; 91(1):37-44. PubMed ID: 1858827 [TBL] [Abstract][Full Text] [Related]
16. The role of circulating immune complexes in the glomerular disease of experimental hepatosplenic schistosomiasis. Digeon M; Droz D; Noel LH; Riza J; Rieumailhol C; Bach JF; Santoro F; Capron A Clin Exp Immunol; 1979 Mar; 35(3):329-37. PubMed ID: 378479 [TBL] [Abstract][Full Text] [Related]
17. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation]. Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289 [TBL] [Abstract][Full Text] [Related]
18. Early liver dysfunction in schistosomiasis. Camacho-Lobato L; Borges DR J Hepatol; 1998 Aug; 29(2):233-40. PubMed ID: 9722204 [TBL] [Abstract][Full Text] [Related]
19. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases. Chamouard P; Grunebaum L; Wiesel ML; Frey PL; Wittersheim C; Sapin R; Baumann R; Cazenave JP Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1183-8. PubMed ID: 8789309 [TBL] [Abstract][Full Text] [Related]
20. Clinical and Preclinical Imaging of Hepatosplenic Schistosomiasis. Masi B; Perles-Barbacaru TA; Bernard M; Viola A Trends Parasitol; 2020 Feb; 36(2):206-226. PubMed ID: 31864895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]